08.05.2023 • News

PCAS in Exclusive Talks for Sale of Canada Business to Japan’s DIC

PCAS, a French specialist in complex molecules for the life sciences and specialty chemicals markets, has received an offer for its Canadian subsidiary from Japanese chemicals company DIC.

© Getty Images/iStockphoto
© Getty Images/iStockphoto

The two companies have now entered into exclusive negotiations — DIC’s offer values PCAS Canada at €88.2 million. A final decision would remain subject to authorization from PCAS’ supervisory board and majority shareholder Seqens, along with other conditions, PCAS said.

PCAS Canada specializes in the synthesis, development and custom manufacture of ingredients used in the formulation of light-sensitive resins, anti-reflective products for microelectronics or as semiconductors for the printed electronics industry. The company also manufactures organic molecules used in pharmaceutical production.

Author: Elaine Burridge, Freelance Journalist

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.